Ringe; Dagmar

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ringe; Dagmar.The latest application filed is for "treatment of amyotrophic lateral sclerosis".

Company Profile

2.6.15

Ringe; Dagmar - Cambridge MA
Ringe; Dagmar - Belmont MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity by UPF1 Grant 11,332,504 - Petsko , et al. May 17, 2	2022-05-17
Treatment Of Amyotrophic Lateral Sclerosis App 20200131236 - Petsko; Greg ; et al.	2020-04-30
Methods of reducing TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis by a UPF1 polypeptide or polynucleotide Grant 10,533,038 - Petsko , et al. Ja	2020-01-14
Ice-cleaved Alpha-synuclein As A Biomarker App 20160143985 - Ringe; Dagmar ; et al.	2016-05-26
Treatment Of Amyloidosis By Compounds That Regulate Retromer Stabilization App 20150361063 - Ringe; Dagmar ; et al.	2015-12-17
Treatment Of Amyotrophic Lateral Sclerosis App 20150259391 - Petsko; Gregory A. ; et al.	2015-09-17
Ice-cleaved alpha-synuclein as a biomarker Grant 9,116,157 - Ringe , et al. August 25, 2	2015-08-25
Ice Inhibiting Compounds And Uses Thereof App 20140309172 - Ringe; Dagmar ; et al.	2014-10-16
Treatment Of Amyloidosis By Compounds That Regulate Retromer Stabilization App 20140288145 - Ringe; Dagmar ; et al.	2014-09-25
Compositions and methods for the diagnosis, treatment, and prevention of amyotrophic lateral sclerosis and related neurological diseases Grant 8,609,649 - Agar , et al. December 17, 2	2013-12-17
Ice-cleaved Alpha-synuclein As A Biomarker App 20130316384 - Ringe; Dagmar ; et al.	2013-11-28
Tetrameric Alpha-synuclein As Biomarkers App 20130309690 - Ringe; Dagmar ; et al.	2013-11-21
Tetrameric Alpha-synuclein And Use Thereof App 20130289022 - Ringe; Dagmar ; et al.	2013-10-31
Compositions And Methods For The Diagnosis, Treatment, And Prevention Of Amyotrophic Lateral Sclerosis And Related Neurological Diseases App 20100152125 - Agar; Jeffrey N. ; et al.	2010-06-17
Computational method for predicting protein interaction sites App 20040148105 - Ondrechen, Mary Jo ; et al.	2004-07-29

Company Registrations

NCAGE Code	45QB7	RINGE DAGMAR
CAGE Code	45QB7	RINGE, DAGMAR

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.